Trial
NCT02628028
A Study of LY3337641 in Rheumatoid Arthritis
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Rheumatoid Arthritis
Intervention
LY3337641
Why stopped
The trial was terminated after an interim analysis of efficacy and safety data did not warrant continuation of the trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-09